Filter posts

The BioGENEius Challenge is a Keystone Event at the BIO International Convention

Part One: A Look Back Read part two of Robert’s story The gathering of leaders …

Diversity Critical to Building Rich Bioscience Centers

Whether producing natural gas from coal or creating lifesaving medicines, unique experiences are what often …

BIO Career Fair: Impress the best

Don’t miss an opportunity to spend a day with hiring managers from the nations’ top …

GEN’s “Top 10” Session Picks for the 2013 BIO International Convention

As the industry moves forward in 2013, it again faces one of its regular bugaboos—uncertainty. …

Forbes 30 Under 30: Rising Biotech Stars at the 2013 BIO International Convention

For the second year in a row, Forbes magazine published a list of the most …

Convention Veterans Putting the “Super” in Super Sessions

Featured in the BIO Buzz Center at last year’s Convention, two of our Super Session …

Navigating the Rare Disease World

The international orphan drug marketplace is expected to grow some 30 percent by 2014, fueled …

Show Me the Money: Reimbursement in an ACA World

A panel at the BIO CEO & Investor Conference focused on reimbursement discussed value from a …

Orphan Drugs: Making Rare Diseases Rarer

A panel at the BIO CEO & Investor Conference provided an analysis of the thriving …

Small Biotech Companies and China: 5 Keys to Success

Big pharmaceutical countries aren’t the only ones investing in China. Emerging and mid-sized biotech companies are also …